CLINICAL TRIALS PROFILE FOR NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE
All Clinical Trials for NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01533220 ↗ | Efficacy of Nasal Naphazoline Hydrocloride + Pheniramine Maleate + Panthenol Compared With Naphazoline Hydrocloride in the Symptomatic Control of Nasal Congestion and Nasopharyngeal | Completed | EMS | Phase 3 | 2013-01-01 | The common cold is a major cause of nasal obstruction and reaches children and adults two or more times a year. At the moment, there is no cure for the common cold, and therefore the reduction of symptoms is the focus of the treatment. The study has parallel distribution design, with two equal groups, in which one group will be treated by a combination of naphazoline hydrocloride + pheniramine maleate + panthenol and the other will receive treatment with naphazoline hydrocloride. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE
Condition Name
Clinical Trial Locations for NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE
Clinical Trial Progress for NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE
Clinical Trial Phase
Clinical Trial Sponsors for NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE
Sponsor Name
